摘要:
The invention provides the use of a compound of formula (I) ##STR1## wherein A, E, F, U, X, Y, Z, are as defined in the specification, or a pharmaceutically acceptable salt thereof, for the treatment of diarrhea predominant irritable bowel syndrome.
摘要:
##STR1## Use of a compound of general formula (I), wherein R 1 represents hydrogen, halogen, trifluoromethyl, nitro, hydroxy, C 1-6 alkyl, C 1-6 alkoxy, arylC 1-6 alkoxy, --CO 2 R 4 , --(CH 2 ) n CN, --(CH 2 ) n CONR 5 R 6 , --(CH 2 ) n SO 2 NR 5 R 6 , C 1-6 alkanoylamino(CH 2 ) n , or C 1-6 alkylsulphonylamino(CH 2 ) n ; R 4 represents hydrogen, C 1-6 alkyl or arylC 1-6 alkyl; R 5 and R 6 each independently represent hydrogen or C 1-6 alkyl, or R 5 and R 6 together with the nitrogen atom to which they are attached form a ring; n represents 0, 1 or 2; and R 2 and R 3 each independently represent hydrogen, C 1-6 alkyl; or benzyl or together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino or hexahydroazepino ring; or a physiologically acceptable salt thereof, in the manufacture of a medicament for the treatment of a condition where a 5-HT 1 -like agonist is indicated, for example migraine. Novel compounds of formula (I), processes for preparing them and pharmaceutical compositions containing them are also described.
摘要:
This invention provides a process for the preparation of 4-(6'-methoxy-2'naphthyl)-butan-2-one, which process comprises the hydrogenation of 4-(6' methoxy-2'-naphthyl)-4-hydroxy-but-3-en-2-one.